| Product Code: ETC12838333 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Influenza B Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Influenza B Market - Industry Life Cycle |
3.4 Argentina Influenza B Market - Porter's Five Forces |
3.5 Argentina Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Argentina Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Argentina Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 Argentina Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Argentina Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination |
4.2.2 Growing prevalence of influenza B virus strains in Argentina |
4.2.3 Government initiatives to promote vaccination campaigns |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost associated with influenza vaccines |
4.3.3 Vaccine hesitancy among certain population groups |
5 Argentina Influenza B Market Trends |
6 Argentina Influenza B Market, By Types |
6.1 Argentina Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Argentina Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 Argentina Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 Argentina Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Argentina Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Argentina Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Argentina Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Argentina Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Argentina Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Argentina Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Argentina Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Argentina Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Argentina Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Argentina Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Argentina Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Argentina Influenza B Market Import-Export Trade Statistics |
7.1 Argentina Influenza B Market Export to Major Countries |
7.2 Argentina Influenza B Market Imports from Major Countries |
8 Argentina Influenza B Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination coverage rates |
8.2 Number of reported cases of influenza B virus strains in Argentina |
8.3 Rate of adoption of new and improved influenza vaccines in the market |
9 Argentina Influenza B Market - Opportunity Assessment |
9.1 Argentina Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Argentina Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Argentina Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 Argentina Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Influenza B Market - Competitive Landscape |
10.1 Argentina Influenza B Market Revenue Share, By Companies, 2024 |
10.2 Argentina Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here